Of note, the strongest decrease of SMARCA2 expression was observed in basal/squamous (p‐value = 5.7E‐10) and luminal papillary (p‐value = 4.48E‐08) molecular BC subtypes (Figure 1d). The gene discussed is SMARCA2; the disease is breast cancer.